December 23, 2003; 61 (12) Articles
Gabapentin in the prophylaxis of chronic daily headache
A randomized, placebo-controlled study
Paul J. Spira, Roy G. Beran
First published December 22, 2003, DOI: https://doi.org/10.1212/01.WNL.0000100121.58594.11
Gabapentin in the prophylaxis of chronic daily headache
A randomized, placebo-controlled study
Paul J. Spira, Roy G. Beran
Neurology Dec 2003, 61 (12) 1753-1759; DOI: 10.1212/01.WNL.0000100121.58594.11
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 61 no. 12 1753-1759
PubMed:
Print ISSN:
Online ISSN:
History:
- Received April 13, 2002
- Accepted September 23, 2003
- First Published December 22, 2003.
Copyright & Usage:
© 2003
Author Disclosures
- Paul J. Spira, MD FRACP,
- Roy G. Beran, MD FRACP and
- for The Australian Gabapentin Chronic Daily Headache Group*
- Paul J. Spira, MD FRACP,
- Roy G. Beran, MD FRACP and
- for The Australian Gabapentin Chronic Daily Headache Group*
- From the Institute of Neurological Sciences (Dr. Spira), Prince of Wales Hospital Randwick; and Strategic Health Evaluators & Department of Neurology (Dr. Beran), Liverpool Hospital, Liverpool NSW Australia.
- Address correspondence and reprint requests to Dr. Roy G. Beran, Suite 5, 6th Floor, 12 Thomas Street, Chatswood 2067, NSW Australia; e-mail: Roy.Beran{at}unsw.edu.au
Article usage
Cited By...
Letters: Rapid online correspondence
- Reply to Nash
- Roy G. Beran, 12 Thomas Street, NSW 2067, Australiaroy.beran@unsw.edu.au
- P.J. Spira
Submitted May 05, 2004 - Gabapentin in the prophylaxis of chronic daily headache: A randomized, placebo-controlled study
- R. A. Nash, 5589 Greenwich Road, Suite 175, Virginia Beach, VA 23462-6564bob@doctornash.com
Submitted May 05, 2004
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan